<img height="1" width="1" style="display:none;" alt="" src="https://px.ads.linkedin.com/collect/?pid=3993628&amp;fmt=gif">

MD Biosciences

Promoting Diversity for Translational Success

In preclinical efficacy studies, several factors are often overlooked, and it is important to...

In Vitro Modeling

The goal of the preclinical development process is to help predict clinical efficacy, emphasizing...

The HTX-011 Story

HTX-011 Breakthrough in Pain Management

ZYNRELEF, the commercial name for HTX-011, is the first and...

Wound Healing Models in Pigs

It is important to bridge the gap between lab findings and clinical applications using...

Advancing Nerve Injury and Repair Models

Understanding Mechanisms Underlying Neuropathic Pain

Porcine Translational Research

Advancing Beyond Rodent and Non-Human Primate Models

While rodent models have contributed...

Increase diversity to improve clinical translation and strengthen pain management outcomes.

The goal of preclinical drug development is to identify potential therapeutic compounds and gain an...